5-Star Stocks Poised to Pop: Stryker

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, orthopedic devices giant Stryker (NYSE: SYK  ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Stryker's business and see what CAPS investors are saying about the stock right now.

Stryker facts

Headquarters (Founded) Kalamazoo, Mich. (1941)
Market Cap $19.5 billion
Industry Healthcare equipment
Trailing-12-Month Revenue $8.1 billion
Management Chairman/CEO Stephen MacMillan
CFO Curt Hartman
Return on Equity (Average, Past 3 Years) 17.7%
Cash/Debt $3.2 billion / $1.8 billion
Dividend Yield 1.7%

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 98% of the 1,473 members who have rated Stryker believe the stock will outperform the S&P 500 going forward.

This past fall, one of those bulls, Cardz, nicely summed up the bull case for our community:

Slow and steady wins the race; [Stryker] may not burn any barns, but its positioned to take advantage of a huge long-term trend in the medical field. People are replacing their hips, knees and other joints regularly now with better surgical techniques and longer life-spans, our bodies just were not built for the long-term abuse we subject them to and [Stryker] will rake in profits as long as there are humans on this planet. I've been an avid investor in this company for decades.

But before you run out and start gobbling up shares, some of Stryker's peers might actually be better suited to your own individual investing profile.

Johnson & Johnson (NYSE: JNJ  ) , for example, boasts a higher dividend yield than Stryker, so it might be better a selection for income-oriented investors. Meanwhile, Medtronic (NYSE: MDT  ) has historically posted much higher returns on equity, giving it the edge in terms of "quality." And Baxter International's (NYSE: BAX  ) lower P/E makes it a more favorable bargain opportunity. However, when you consider that Stryker is expected to grow its bottom line at a faster rate than each of its peers mentioned above, the stock seems nicely suited for investors looking for a low-risk way to go for growth.

What do you think about Stryker, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of Johnson & Johnson and Medtronic. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson and Stryker. Motley Fool newsletter services have recommended creating a diagonal call position in Johnson & Johnson. 

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1752320, ~/Articles/ArticleHandler.aspx, 10/1/2014 10:51:31 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement